Ethyl 2-chloroacetoacetate
Based on 1 Customer Validation
Ethyl 2-chloroacetoacetate (A 21960) is a chloroacetoacetate ester and also an alkylation building block for synthesis. Ethyl 2-chloroacetoacetate can serve as a starting material to undergo diazotization with aniline to generate a phenyltriazole-derived N-capping group, followed by cyclization with acetaldoxime. Ethyl 2-chloroacetoacetate can be used to synthesize steroidal thiazole and oxazole derivatives, which exhibit antimicrobial activity against Staphylococcus aureus, Listeria monocytogenes, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Cryptococcus neoformans.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 98.0%
- CAS. Nr.: 609-15-4
- Formel: C6H9ClO3
- Molecular Weight:164.59
-
Speicherung:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biologische Aktivität
Beschreibung
In Vitro
Ethyl 2-chloroacetoacetate is a key reagent for the preparation of oxazole and imidazole intermediates in the synthesis of C3aR ligands[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 609-15-4
-
Appearance Liquid (Density: 1.172 g/cm3)
-
Molecular Weight 164.59
-
Formel C6H9ClO3
-
Color Colorless to light yellow
-
SMILES
O=C(C(C(C)=O)Cl)OCC
-
Synonyms
A 21960
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : 100 mg/mL (607.57 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
Reinheit & Dokumentation
-
Data Sheet (273 KB)
-
SDS (759 KB)
- English - EN (759 KB)
- Français - FR (759 KB)
- Deutsch - DE (759 KB)
- Norwegian - NO (759 KB)
- Español - ES (759 KB)
- Swedish - SV (759 KB)
- Italian - IT (759 KB)
- Korean - KR (759 KB)
- Portuguese - PT (759 KB)
-
Handling Instructions (2659 KB)
Verweise
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Synaptic Plasticity & Brain Health
Synaptic plasticity is the activity-, experience-, development-, and injury-dependent modification of synaptic strength, number, and structure, and it remains a central mechanism for learning, memory, sensory adaptation, and brain health.
2026-06-18
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 6.0757 mL | 30.3785 mL | 60.7570 mL | 151.8926 mL |
| 5 mM | 1.2151 mL | 6.0757 mL | 12.1514 mL | 30.3785 mL | |
| 10 mM | 0.6076 mL | 3.0379 mL | 6.0757 mL | 15.1893 mL | |
| 15 mM | 0.4050 mL | 2.0252 mL | 4.0505 mL | 10.1262 mL | |
| 20 mM | 0.3038 mL | 1.5189 mL | 3.0379 mL | 7.5946 mL | |
| 25 mM | 0.2430 mL | 1.2151 mL | 2.4303 mL | 6.0757 mL | |
| 30 mM | 0.2025 mL | 1.0126 mL | 2.0252 mL | 5.0631 mL | |
| 40 mM | 0.1519 mL | 0.7595 mL | 1.5189 mL | 3.7973 mL | |
| 50 mM | 0.1215 mL | 0.6076 mL | 1.2151 mL | 3.0379 mL | |
| 60 mM | 0.1013 mL | 0.5063 mL | 1.0126 mL | 2.5315 mL | |
| 80 mM | 0.0759 mL | 0.3797 mL | 0.7595 mL | 1.8987 mL | |
| 100 mM | 0.0608 mL | 0.3038 mL | 0.6076 mL | 1.5189 mL |
Keywords
- Ethyl 2-chloroacetoacetate
- 609-15-4
- A 21960
- A21960
- A-21960
- Drug Intermediate
- Drug Iintermediate
- semicarbazide
- antimicrobial activity
- steroidal thiazole and oxazole derivatives
- diazonium reactions
- thiosemicarbazide
- inflammatory diseases
- acetaldehyde oxime
- C3aR ligands
- aniline
- phenyltriazole-derived N-capping groups
- Inhibitor
- inhibitor
- inhibit